Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
30.0%
% of XPH's 40 holdings also in PPH
52.2%
% of PPH's 26 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XPH |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 4.3% | 13.8% | 4.3% | |
JOHNSON & JOHNSON | 4.1% | 7.2% | 4.1% | |
ZOETIS INC | 3.9% | 4.7% | 3.9% | |
PFIZER INC | 3.7% | 4.4% | 3.7% | |
MERCK & CO. INC. | 3.6% | 4.8% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
CORCEPT THERAPEUTICS INC | 4.8% | |
TARSUS PHARMACEUTICALS, INC. | 4.2% | |
ROYALTY PHARMA PLC CLASS A | 4.2% | |
PRESTIGE BRANDS HOLDINGS INC | 3.9% | |
PACIRA PHARMACEUTICALS INC | 3.2% | |
PERRIGO CO | 3.0% | |
ARVINAS, INC. | 2.8% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.8% | |
AXSOME THERAPEUTICS, INC. | 2.6% | |
ELANCO ANIMAL HEALTH, INC. | 2.5% |
XPH Underweight Relative to PPH
ELI LILLY & CO | -9.4% | |
ABBVIE INC | -6.3% | |
NOVARTIS AG-ADR | -5.8% | |
CENCORA INC | -5.8% | |
MCKESSON CORP | -5.6% | |
ASTRAZENECA PLC-SPONS ADR | -5.1% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -5.1% | |
SANOFI-AVENTIS-ADR | -5.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | -4.8% | |
NOVO-NORDISK A/S-SPONS ADR | -4.4% |